Global Anti-radiation Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Anti-radiation Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Anti-radiation Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Anti-radiation Drugs market. Anti-radiation Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-radiation Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-radiation Drugs market.
Anti-radiation drugs offer protection against radiation exposure. These drugs include Kl,Prussian Blue, and DTPA (Diethylenetriamine pentaacetate). Anti-radiation medicines help block the absorption and subsequent concentration of radioactive iodine in the thyroid gland. KI must be consumed before or shortly after exposure to radioactive iodine for better results.It is effective only against radioactive iodine and not against other types of radiation. Oxidation of ferrous ferrocyanide salts produces Prussian blue that is used for the treatment of thallium poisoning or radioactive cesium poisoning.
Key Features:
The report on Anti-radiation Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-radiation Drugs market. It may include historical data, market segmentation by Type (e.g., Potassium lodide (KI), Prussian Blue), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-radiation Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-radiation Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-radiation Drugs industry. This include advancements in Anti-radiation Drugs technology, Anti-radiation Drugs new entrants, Anti-radiation Drugs new investment, and other innovations that are shaping the future of Anti-radiation Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-radiation Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-radiation Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-radiation Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-radiation Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-radiation Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-radiation Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-radiation Drugs market.
Market Segmentation:
Anti-radiation Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Anti-radiation Drugs market?
What factors are driving Anti-radiation Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-radiation Drugs market opportunities vary by end market size?
How does Anti-radiation Drugs break out type, application?
According to our LPI (LP Information) latest study, the global Anti-radiation Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Anti-radiation Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Anti-radiation Drugs market. Anti-radiation Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-radiation Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-radiation Drugs market.
Anti-radiation drugs offer protection against radiation exposure. These drugs include Kl,Prussian Blue, and DTPA (Diethylenetriamine pentaacetate). Anti-radiation medicines help block the absorption and subsequent concentration of radioactive iodine in the thyroid gland. KI must be consumed before or shortly after exposure to radioactive iodine for better results.It is effective only against radioactive iodine and not against other types of radiation. Oxidation of ferrous ferrocyanide salts produces Prussian blue that is used for the treatment of thallium poisoning or radioactive cesium poisoning.
Key Features:
The report on Anti-radiation Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-radiation Drugs market. It may include historical data, market segmentation by Type (e.g., Potassium lodide (KI), Prussian Blue), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-radiation Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-radiation Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-radiation Drugs industry. This include advancements in Anti-radiation Drugs technology, Anti-radiation Drugs new entrants, Anti-radiation Drugs new investment, and other innovations that are shaping the future of Anti-radiation Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-radiation Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-radiation Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-radiation Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-radiation Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-radiation Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-radiation Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-radiation Drugs market.
Market Segmentation:
Anti-radiation Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Potassium lodide (KI)
- Prussian Blue
- DTPA (Diethylenetriamine Pentaacetate)
- Others
- Acute Radiation Syndrome(ARS)
- Cancer Treatment
- Radiation Exposure
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Anbex
- BTG International
- Cellphire
- Chrysalis BioTherapeutics
- Darnitsa
- Enzychem Lifesciences
- Humanetics
- Mission Pharmacal
- Partner Therapeutics
- Myelo Therapeutics
- Pluri
What is the 10-year outlook for the global Anti-radiation Drugs market?
What factors are driving Anti-radiation Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-radiation Drugs market opportunities vary by end market size?
How does Anti-radiation Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-radiation Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-radiation Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-radiation Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-radiation Drugs Segment by Type
2.2.1 Potassium lodide (KI)
2.2.2 Prussian Blue
2.2.3 DTPA (Diethylenetriamine Pentaacetate)
2.2.4 Others
2.3 Anti-radiation Drugs Sales by Type
2.3.1 Global Anti-radiation Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-radiation Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-radiation Drugs Sale Price by Type (2018-2023)
2.4 Anti-radiation Drugs Segment by Application
2.4.1 Acute Radiation Syndrome(ARS)
2.4.2 Cancer Treatment
2.4.3 Radiation Exposure
2.4.4 Others
2.5 Anti-radiation Drugs Sales by Application
2.5.1 Global Anti-radiation Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-radiation Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-radiation Drugs Sale Price by Application (2018-2023)
3 GLOBAL ANTI-RADIATION DRUGS BY COMPANY
3.1 Global Anti-radiation Drugs Breakdown Data by Company
3.1.1 Global Anti-radiation Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-radiation Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-radiation Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-radiation Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-radiation Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-radiation Drugs Sale Price by Company
3.4 Key Manufacturers Anti-radiation Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-radiation Drugs Product Location Distribution
3.4.2 Players Anti-radiation Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-RADIATION DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-radiation Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-radiation Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-radiation Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-radiation Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-radiation Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-radiation Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-radiation Drugs Sales Growth
4.4 APAC Anti-radiation Drugs Sales Growth
4.5 Europe Anti-radiation Drugs Sales Growth
4.6 Middle East & Africa Anti-radiation Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-radiation Drugs Sales by Country
5.1.1 Americas Anti-radiation Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-radiation Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-radiation Drugs Sales by Type
5.3 Americas Anti-radiation Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-radiation Drugs Sales by Region
6.1.1 APAC Anti-radiation Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-radiation Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-radiation Drugs Sales by Type
6.3 APAC Anti-radiation Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-radiation Drugs by Country
7.1.1 Europe Anti-radiation Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-radiation Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-radiation Drugs Sales by Type
7.3 Europe Anti-radiation Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-radiation Drugs by Country
8.1.1 Middle East & Africa Anti-radiation Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-radiation Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-radiation Drugs Sales by Type
8.3 Middle East & Africa Anti-radiation Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-radiation Drugs
10.3 Manufacturing Process Analysis of Anti-radiation Drugs
10.4 Industry Chain Structure of Anti-radiation Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-radiation Drugs Distributors
11.3 Anti-radiation Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-RADIATION DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-radiation Drugs Market Size Forecast by Region
12.1.1 Global Anti-radiation Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-radiation Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-radiation Drugs Forecast by Type
12.7 Global Anti-radiation Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Anti-radiation Drugs Product Portfolios and Specifications
13.1.3 Amgen Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Anbex
13.2.1 Anbex Company Information
13.2.2 Anbex Anti-radiation Drugs Product Portfolios and Specifications
13.2.3 Anbex Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Anbex Main Business Overview
13.2.5 Anbex Latest Developments
13.3 BTG International
13.3.1 BTG International Company Information
13.3.2 BTG International Anti-radiation Drugs Product Portfolios and Specifications
13.3.3 BTG International Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BTG International Main Business Overview
13.3.5 BTG International Latest Developments
13.4 Cellphire
13.4.1 Cellphire Company Information
13.4.2 Cellphire Anti-radiation Drugs Product Portfolios and Specifications
13.4.3 Cellphire Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cellphire Main Business Overview
13.4.5 Cellphire Latest Developments
13.5 Chrysalis BioTherapeutics
13.5.1 Chrysalis BioTherapeutics Company Information
13.5.2 Chrysalis BioTherapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.5.3 Chrysalis BioTherapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chrysalis BioTherapeutics Main Business Overview
13.5.5 Chrysalis BioTherapeutics Latest Developments
13.6 Darnitsa
13.6.1 Darnitsa Company Information
13.6.2 Darnitsa Anti-radiation Drugs Product Portfolios and Specifications
13.6.3 Darnitsa Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Darnitsa Main Business Overview
13.6.5 Darnitsa Latest Developments
13.7 Enzychem Lifesciences
13.7.1 Enzychem Lifesciences Company Information
13.7.2 Enzychem Lifesciences Anti-radiation Drugs Product Portfolios and Specifications
13.7.3 Enzychem Lifesciences Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Enzychem Lifesciences Main Business Overview
13.7.5 Enzychem Lifesciences Latest Developments
13.8 Humanetics
13.8.1 Humanetics Company Information
13.8.2 Humanetics Anti-radiation Drugs Product Portfolios and Specifications
13.8.3 Humanetics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Humanetics Main Business Overview
13.8.5 Humanetics Latest Developments
13.9 Mission Pharmacal
13.9.1 Mission Pharmacal Company Information
13.9.2 Mission Pharmacal Anti-radiation Drugs Product Portfolios and Specifications
13.9.3 Mission Pharmacal Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mission Pharmacal Main Business Overview
13.9.5 Mission Pharmacal Latest Developments
13.10 Partner Therapeutics
13.10.1 Partner Therapeutics Company Information
13.10.2 Partner Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.10.3 Partner Therapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Partner Therapeutics Main Business Overview
13.10.5 Partner Therapeutics Latest Developments
13.11 Myelo Therapeutics
13.11.1 Myelo Therapeutics Company Information
13.11.2 Myelo Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.11.3 Myelo Therapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Myelo Therapeutics Main Business Overview
13.11.5 Myelo Therapeutics Latest Developments
13.12 Pluri
13.12.1 Pluri Company Information
13.12.2 Pluri Anti-radiation Drugs Product Portfolios and Specifications
13.12.3 Pluri Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Pluri Main Business Overview
13.12.5 Pluri Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-radiation Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-radiation Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-radiation Drugs by Country/Region, 2018, 2022 & 2029
2.2 Anti-radiation Drugs Segment by Type
2.2.1 Potassium lodide (KI)
2.2.2 Prussian Blue
2.2.3 DTPA (Diethylenetriamine Pentaacetate)
2.2.4 Others
2.3 Anti-radiation Drugs Sales by Type
2.3.1 Global Anti-radiation Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-radiation Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-radiation Drugs Sale Price by Type (2018-2023)
2.4 Anti-radiation Drugs Segment by Application
2.4.1 Acute Radiation Syndrome(ARS)
2.4.2 Cancer Treatment
2.4.3 Radiation Exposure
2.4.4 Others
2.5 Anti-radiation Drugs Sales by Application
2.5.1 Global Anti-radiation Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-radiation Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-radiation Drugs Sale Price by Application (2018-2023)
3 GLOBAL ANTI-RADIATION DRUGS BY COMPANY
3.1 Global Anti-radiation Drugs Breakdown Data by Company
3.1.1 Global Anti-radiation Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Anti-radiation Drugs Sales Market Share by Company (2018-2023)
3.2 Global Anti-radiation Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-radiation Drugs Revenue by Company (2018-2023)
3.2.2 Global Anti-radiation Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Anti-radiation Drugs Sale Price by Company
3.4 Key Manufacturers Anti-radiation Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-radiation Drugs Product Location Distribution
3.4.2 Players Anti-radiation Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-RADIATION DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-radiation Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-radiation Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-radiation Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-radiation Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-radiation Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-radiation Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-radiation Drugs Sales Growth
4.4 APAC Anti-radiation Drugs Sales Growth
4.5 Europe Anti-radiation Drugs Sales Growth
4.6 Middle East & Africa Anti-radiation Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-radiation Drugs Sales by Country
5.1.1 Americas Anti-radiation Drugs Sales by Country (2018-2023)
5.1.2 Americas Anti-radiation Drugs Revenue by Country (2018-2023)
5.2 Americas Anti-radiation Drugs Sales by Type
5.3 Americas Anti-radiation Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-radiation Drugs Sales by Region
6.1.1 APAC Anti-radiation Drugs Sales by Region (2018-2023)
6.1.2 APAC Anti-radiation Drugs Revenue by Region (2018-2023)
6.2 APAC Anti-radiation Drugs Sales by Type
6.3 APAC Anti-radiation Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-radiation Drugs by Country
7.1.1 Europe Anti-radiation Drugs Sales by Country (2018-2023)
7.1.2 Europe Anti-radiation Drugs Revenue by Country (2018-2023)
7.2 Europe Anti-radiation Drugs Sales by Type
7.3 Europe Anti-radiation Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-radiation Drugs by Country
8.1.1 Middle East & Africa Anti-radiation Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-radiation Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-radiation Drugs Sales by Type
8.3 Middle East & Africa Anti-radiation Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-radiation Drugs
10.3 Manufacturing Process Analysis of Anti-radiation Drugs
10.4 Industry Chain Structure of Anti-radiation Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-radiation Drugs Distributors
11.3 Anti-radiation Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-RADIATION DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-radiation Drugs Market Size Forecast by Region
12.1.1 Global Anti-radiation Drugs Forecast by Region (2024-2029)
12.1.2 Global Anti-radiation Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-radiation Drugs Forecast by Type
12.7 Global Anti-radiation Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Anti-radiation Drugs Product Portfolios and Specifications
13.1.3 Amgen Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Anbex
13.2.1 Anbex Company Information
13.2.2 Anbex Anti-radiation Drugs Product Portfolios and Specifications
13.2.3 Anbex Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Anbex Main Business Overview
13.2.5 Anbex Latest Developments
13.3 BTG International
13.3.1 BTG International Company Information
13.3.2 BTG International Anti-radiation Drugs Product Portfolios and Specifications
13.3.3 BTG International Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BTG International Main Business Overview
13.3.5 BTG International Latest Developments
13.4 Cellphire
13.4.1 Cellphire Company Information
13.4.2 Cellphire Anti-radiation Drugs Product Portfolios and Specifications
13.4.3 Cellphire Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cellphire Main Business Overview
13.4.5 Cellphire Latest Developments
13.5 Chrysalis BioTherapeutics
13.5.1 Chrysalis BioTherapeutics Company Information
13.5.2 Chrysalis BioTherapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.5.3 Chrysalis BioTherapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chrysalis BioTherapeutics Main Business Overview
13.5.5 Chrysalis BioTherapeutics Latest Developments
13.6 Darnitsa
13.6.1 Darnitsa Company Information
13.6.2 Darnitsa Anti-radiation Drugs Product Portfolios and Specifications
13.6.3 Darnitsa Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Darnitsa Main Business Overview
13.6.5 Darnitsa Latest Developments
13.7 Enzychem Lifesciences
13.7.1 Enzychem Lifesciences Company Information
13.7.2 Enzychem Lifesciences Anti-radiation Drugs Product Portfolios and Specifications
13.7.3 Enzychem Lifesciences Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Enzychem Lifesciences Main Business Overview
13.7.5 Enzychem Lifesciences Latest Developments
13.8 Humanetics
13.8.1 Humanetics Company Information
13.8.2 Humanetics Anti-radiation Drugs Product Portfolios and Specifications
13.8.3 Humanetics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Humanetics Main Business Overview
13.8.5 Humanetics Latest Developments
13.9 Mission Pharmacal
13.9.1 Mission Pharmacal Company Information
13.9.2 Mission Pharmacal Anti-radiation Drugs Product Portfolios and Specifications
13.9.3 Mission Pharmacal Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mission Pharmacal Main Business Overview
13.9.5 Mission Pharmacal Latest Developments
13.10 Partner Therapeutics
13.10.1 Partner Therapeutics Company Information
13.10.2 Partner Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.10.3 Partner Therapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Partner Therapeutics Main Business Overview
13.10.5 Partner Therapeutics Latest Developments
13.11 Myelo Therapeutics
13.11.1 Myelo Therapeutics Company Information
13.11.2 Myelo Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
13.11.3 Myelo Therapeutics Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Myelo Therapeutics Main Business Overview
13.11.5 Myelo Therapeutics Latest Developments
13.12 Pluri
13.12.1 Pluri Company Information
13.12.2 Pluri Anti-radiation Drugs Product Portfolios and Specifications
13.12.3 Pluri Anti-radiation Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Pluri Main Business Overview
13.12.5 Pluri Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-radiation Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-radiation Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Potassium lodide (KI)
Table 4. Major Players of Prussian Blue
Table 5. Major Players of DTPA (Diethylenetriamine Pentaacetate)
Table 6. Major Players of Others
Table 7. Global Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Anti-radiation Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-radiation Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-radiation Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Anti-radiation Drugs Revenue by Application (2018-2023)
Table 15. Global Anti-radiation Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-radiation Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti-radiation Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti-radiation Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Anti-radiation Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-radiation Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-radiation Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti-radiation Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-radiation Drugs Products Offered
Table 24. Anti-radiation Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-radiation Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti-radiation Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-radiation Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-radiation Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-radiation Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti-radiation Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-radiation Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-radiation Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti-radiation Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti-radiation Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-radiation Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-radiation Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-radiation Drugs
Table 60. Key Market Challenges & Risks of Anti-radiation Drugs
Table 61. Key Industry Trends of Anti-radiation Drugs
Table 62. Anti-radiation Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-radiation Drugs Distributors List
Table 65. Anti-radiation Drugs Customer List
Table 66. Global Anti-radiation Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti-radiation Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-radiation Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti-radiation Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-radiation Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti-radiation Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-radiation Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti-radiation Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Amgen Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Anti-radiation Drugs Product Portfolios and Specifications
Table 82. Amgen Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85. Anbex Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Anbex Anti-radiation Drugs Product Portfolios and Specifications
Table 87. Anbex Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Anbex Main Business
Table 89. Anbex Latest Developments
Table 90. BTG International Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. BTG International Anti-radiation Drugs Product Portfolios and Specifications
Table 92. BTG International Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BTG International Main Business
Table 94. BTG International Latest Developments
Table 95. Cellphire Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Cellphire Anti-radiation Drugs Product Portfolios and Specifications
Table 97. Cellphire Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cellphire Main Business
Table 99. Cellphire Latest Developments
Table 100. Chrysalis BioTherapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Chrysalis BioTherapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 102. Chrysalis BioTherapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Chrysalis BioTherapeutics Main Business
Table 104. Chrysalis BioTherapeutics Latest Developments
Table 105. Darnitsa Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Darnitsa Anti-radiation Drugs Product Portfolios and Specifications
Table 107. Darnitsa Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Darnitsa Main Business
Table 109. Darnitsa Latest Developments
Table 110. Enzychem Lifesciences Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Enzychem Lifesciences Anti-radiation Drugs Product Portfolios and Specifications
Table 112. Enzychem Lifesciences Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Enzychem Lifesciences Main Business
Table 114. Enzychem Lifesciences Latest Developments
Table 115. Humanetics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Humanetics Anti-radiation Drugs Product Portfolios and Specifications
Table 117. Humanetics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Humanetics Main Business
Table 119. Humanetics Latest Developments
Table 120. Mission Pharmacal Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Mission Pharmacal Anti-radiation Drugs Product Portfolios and Specifications
Table 122. Mission Pharmacal Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Mission Pharmacal Main Business
Table 124. Mission Pharmacal Latest Developments
Table 125. Partner Therapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Partner Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 127. Partner Therapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Partner Therapeutics Main Business
Table 129. Partner Therapeutics Latest Developments
Table 130. Myelo Therapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Myelo Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 132. Myelo Therapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Myelo Therapeutics Main Business
Table 134. Myelo Therapeutics Latest Developments
Table 135. Pluri Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Pluri Anti-radiation Drugs Product Portfolios and Specifications
Table 137. Pluri Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Pluri Main Business
Table 139. Pluri Latest Developments
Table 1. Anti-radiation Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-radiation Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Potassium lodide (KI)
Table 4. Major Players of Prussian Blue
Table 5. Major Players of DTPA (Diethylenetriamine Pentaacetate)
Table 6. Major Players of Others
Table 7. Global Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Anti-radiation Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-radiation Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-radiation Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Anti-radiation Drugs Revenue by Application (2018-2023)
Table 15. Global Anti-radiation Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-radiation Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti-radiation Drugs Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti-radiation Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Anti-radiation Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-radiation Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-radiation Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti-radiation Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-radiation Drugs Products Offered
Table 24. Anti-radiation Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-radiation Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti-radiation Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-radiation Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-radiation Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-radiation Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti-radiation Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-radiation Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-radiation Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti-radiation Drugs Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti-radiation Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-radiation Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-radiation Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-radiation Drugs Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti-radiation Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-radiation Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-radiation Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-radiation Drugs Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti-radiation Drugs Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-radiation Drugs
Table 60. Key Market Challenges & Risks of Anti-radiation Drugs
Table 61. Key Industry Trends of Anti-radiation Drugs
Table 62. Anti-radiation Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-radiation Drugs Distributors List
Table 65. Anti-radiation Drugs Customer List
Table 66. Global Anti-radiation Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti-radiation Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-radiation Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti-radiation Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-radiation Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti-radiation Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-radiation Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti-radiation Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-radiation Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti-radiation Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Amgen Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Anti-radiation Drugs Product Portfolios and Specifications
Table 82. Amgen Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Amgen Main Business
Table 84. Amgen Latest Developments
Table 85. Anbex Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Anbex Anti-radiation Drugs Product Portfolios and Specifications
Table 87. Anbex Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Anbex Main Business
Table 89. Anbex Latest Developments
Table 90. BTG International Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. BTG International Anti-radiation Drugs Product Portfolios and Specifications
Table 92. BTG International Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. BTG International Main Business
Table 94. BTG International Latest Developments
Table 95. Cellphire Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Cellphire Anti-radiation Drugs Product Portfolios and Specifications
Table 97. Cellphire Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Cellphire Main Business
Table 99. Cellphire Latest Developments
Table 100. Chrysalis BioTherapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Chrysalis BioTherapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 102. Chrysalis BioTherapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Chrysalis BioTherapeutics Main Business
Table 104. Chrysalis BioTherapeutics Latest Developments
Table 105. Darnitsa Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Darnitsa Anti-radiation Drugs Product Portfolios and Specifications
Table 107. Darnitsa Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Darnitsa Main Business
Table 109. Darnitsa Latest Developments
Table 110. Enzychem Lifesciences Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Enzychem Lifesciences Anti-radiation Drugs Product Portfolios and Specifications
Table 112. Enzychem Lifesciences Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Enzychem Lifesciences Main Business
Table 114. Enzychem Lifesciences Latest Developments
Table 115. Humanetics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Humanetics Anti-radiation Drugs Product Portfolios and Specifications
Table 117. Humanetics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Humanetics Main Business
Table 119. Humanetics Latest Developments
Table 120. Mission Pharmacal Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Mission Pharmacal Anti-radiation Drugs Product Portfolios and Specifications
Table 122. Mission Pharmacal Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Mission Pharmacal Main Business
Table 124. Mission Pharmacal Latest Developments
Table 125. Partner Therapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Partner Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 127. Partner Therapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Partner Therapeutics Main Business
Table 129. Partner Therapeutics Latest Developments
Table 130. Myelo Therapeutics Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Myelo Therapeutics Anti-radiation Drugs Product Portfolios and Specifications
Table 132. Myelo Therapeutics Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Myelo Therapeutics Main Business
Table 134. Myelo Therapeutics Latest Developments
Table 135. Pluri Basic Information, Anti-radiation Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Pluri Anti-radiation Drugs Product Portfolios and Specifications
Table 137. Pluri Anti-radiation Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Pluri Main Business
Table 139. Pluri Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-radiation Drugs
Figure 2. Anti-radiation Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-radiation Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-radiation Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-radiation Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Potassium lodide (KI)
Figure 10. Product Picture of Prussian Blue
Figure 11. Product Picture of DTPA (Diethylenetriamine Pentaacetate)
Figure 12. Product Picture of Others
Figure 13. Global Anti-radiation Drugs Sales Market Share by Type in 2022
Figure 14. Global Anti-radiation Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Anti-radiation Drugs Consumed in Acute Radiation Syndrome(ARS)
Figure 16. Global Anti-radiation Drugs Market: Acute Radiation Syndrome(ARS) (2018-2023) & (K Units)
Figure 17. Anti-radiation Drugs Consumed in Cancer Treatment
Figure 18. Global Anti-radiation Drugs Market: Cancer Treatment (2018-2023) & (K Units)
Figure 19. Anti-radiation Drugs Consumed in Radiation Exposure
Figure 20. Global Anti-radiation Drugs Market: Radiation Exposure (2018-2023) & (K Units)
Figure 21. Anti-radiation Drugs Consumed in Others
Figure 22. Global Anti-radiation Drugs Market: Others (2018-2023) & (K Units)
Figure 23. Global Anti-radiation Drugs Sales Market Share by Application (2022)
Figure 24. Global Anti-radiation Drugs Revenue Market Share by Application in 2022
Figure 25. Anti-radiation Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Anti-radiation Drugs Sales Market Share by Company in 2022
Figure 27. Anti-radiation Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-radiation Drugs Revenue Market Share by Company in 2022
Figure 29. Global Anti-radiation Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-radiation Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 40. Americas Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-radiation Drugs Sales Market Share by Region in 2022
Figure 48. APAC Anti-radiation Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 59. Europe Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-radiation Drugs in 2022
Figure 77. Manufacturing Process Analysis of Anti-radiation Drugs
Figure 78. Industry Chain Structure of Anti-radiation Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-radiation Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-radiation Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-radiation Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-radiation Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-radiation Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-radiation Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Anti-radiation Drugs
Figure 2. Anti-radiation Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-radiation Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-radiation Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-radiation Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Potassium lodide (KI)
Figure 10. Product Picture of Prussian Blue
Figure 11. Product Picture of DTPA (Diethylenetriamine Pentaacetate)
Figure 12. Product Picture of Others
Figure 13. Global Anti-radiation Drugs Sales Market Share by Type in 2022
Figure 14. Global Anti-radiation Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Anti-radiation Drugs Consumed in Acute Radiation Syndrome(ARS)
Figure 16. Global Anti-radiation Drugs Market: Acute Radiation Syndrome(ARS) (2018-2023) & (K Units)
Figure 17. Anti-radiation Drugs Consumed in Cancer Treatment
Figure 18. Global Anti-radiation Drugs Market: Cancer Treatment (2018-2023) & (K Units)
Figure 19. Anti-radiation Drugs Consumed in Radiation Exposure
Figure 20. Global Anti-radiation Drugs Market: Radiation Exposure (2018-2023) & (K Units)
Figure 21. Anti-radiation Drugs Consumed in Others
Figure 22. Global Anti-radiation Drugs Market: Others (2018-2023) & (K Units)
Figure 23. Global Anti-radiation Drugs Sales Market Share by Application (2022)
Figure 24. Global Anti-radiation Drugs Revenue Market Share by Application in 2022
Figure 25. Anti-radiation Drugs Sales Market by Company in 2022 (K Units)
Figure 26. Global Anti-radiation Drugs Sales Market Share by Company in 2022
Figure 27. Anti-radiation Drugs Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-radiation Drugs Revenue Market Share by Company in 2022
Figure 29. Global Anti-radiation Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-radiation Drugs Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 32. Americas Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 34. APAC Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 36. Europe Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-radiation Drugs Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Anti-radiation Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 40. Americas Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 41. Americas Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-radiation Drugs Sales Market Share by Region in 2022
Figure 48. APAC Anti-radiation Drugs Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 51. China Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 59. Europe Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 60. Europe Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-radiation Drugs Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-radiation Drugs Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-radiation Drugs Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-radiation Drugs Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-radiation Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-radiation Drugs in 2022
Figure 77. Manufacturing Process Analysis of Anti-radiation Drugs
Figure 78. Industry Chain Structure of Anti-radiation Drugs
Figure 79. Channels of Distribution
Figure 80. Global Anti-radiation Drugs Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-radiation Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-radiation Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-radiation Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-radiation Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-radiation Drugs Revenue Market Share Forecast by Application (2024-2029)
